Structure and design of Langya virus glycoprotein antigens

Langya virus (LayV) is a recently discovered henipavirus (HNV), isolated from febrile patients in China. HNV entry into host cells is mediated by the attachment (G) and fusion (F) glycoproteins which are the main targets of neutralizing antibodies. We show here that the LayV F and G glycoproteins promote membrane fusion with human, mouse, and hamster target cells using a different, yet unknown, receptor than Nipah virus (NiV) and Hendra virus (HeV) and that NiV- and HeV-elicited monoclonal and polyclonal antibodies do not cross-react with LayV F and G. We determined cryoelectron microscopy structures of LayV F, in the prefusion and postfusion states, and of LayV G, revealing their conformational landscape and distinct antigenicity relative to NiV and HeV. We computationally designed stabilized LayV G constructs and demonstrate the generalizability of an HNV F prefusion-stabilization strategy. Our data will support the development of vaccines and therapeutics against LayV and closely related HNVs.

Errataetall:

UpdateOf: bioRxiv. 2023 Aug 26;:. - PMID 37645760

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:121

Enthalten in:

Proceedings of the National Academy of Sciences of the United States of America - 121(2024), 16 vom: 16. Apr., Seite e2314990121

Sprache:

Englisch

Beteiligte Personen:

Wang, Zhaoqian [VerfasserIn]
McCallum, Matthew [VerfasserIn]
Yan, Lianying [VerfasserIn]
Gibson, Cecily A [VerfasserIn]
Sharkey, William [VerfasserIn]
Park, Young-Jun [VerfasserIn]
Dang, Ha V [VerfasserIn]
Amaya, Moushimi [VerfasserIn]
Person, Ashley [VerfasserIn]
Broder, Christopher C [VerfasserIn]
Veesler, David [VerfasserIn]

Links:

Volltext

Themen:

Antibodies
CryoEM
Glycoproteins
Henipavirus
Journal Article
Langya virus
Vaccine design

Anmerkungen:

Date Completed 11.04.2024

Date Revised 29.04.2024

published: Print-Electronic

UpdateOf: bioRxiv. 2023 Aug 26;:. - PMID 37645760

Citation Status MEDLINE

doi:

10.1073/pnas.2314990121

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM37082413X